Thrombocytopenia After Gemtuzumab Is Reversible by Intravenous Immunoglobulin

Leukemia- United Kingdom

doi 10.1038/sj.leu.2403757

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search